Literature DB >> 21444709

Emergence of Escherichia coli sequence type ST131 carrying both the blaGES-5 and blaCTX-M-15 genes.

Juwon Kim1, Seong Geun Hong, Il Kwon Bae, Ji Roung Kang, Seok Hoon Jeong, Wookeun Lee, Kyungwon Lee.   

Abstract

Escherichia coli clinical isolate BD07372 of sequence type ST131 recovered from a bed sore specimen exhibited high-level resistance to ceftazidime and cefotaxime but exhibited susceptibility to imipenem and meropenem. The isolate harbored two β-lactamase genes, the bla(CTX-M-15) gene carried by an ∼250-kbp plasmid carrying the FIA and FIC replicons and the bla(GES-5) gene carried by a class 1 integron in the chromosome.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21444709      PMCID： PMC3101397          DOI： 10.1128/AAC.01703-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli.

Authors:  Kyungwon Lee; Chang Ki Kim; Dongeun Yong; Seok Hoon Jeong; Jong Hwa Yum; Young Hee Seo; Jean-Denis Docquier; Yunsop Chong
Journal:  J Microbiol Methods       Date:  2010-08-27       Impact factor: 2.363

2.  Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants.

Authors:  Laura Villa; Aurora García-Fernández; Daniela Fortini; Alessandra Carattoli
Journal:  J Antimicrob Chemother       Date:  2010-10-08       Impact factor: 5.790

3.  Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytoca.

Authors:  H Bermudes; F Jude; E B Chaibi; C Arpin; C Bebear; R Labia; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

4.  A general method for detecting and sizing large plasmids.

Authors:  B M Barton; G P Harding; A J Zuccarelli
Journal:  Anal Biochem       Date:  1995-04-10       Impact factor: 3.365

Review 5.  Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact.

Authors:  Jesús Oteo; María Pérez-Vázquez; José Campos
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

6.  Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum beta-lactamases in nursing homes in Belfast, UK.

Authors:  Hiran Dhanji; Michel Doumith; Paul J Rooney; Maureen C O'Leary; Anne C Loughrey; Russell Hope; Neil Woodford; David M Livermore
Journal:  J Antimicrob Chemother       Date:  2010-12-03       Impact factor: 5.790

7.  GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium.

Authors:  Pierre Bogaerts; Thierry Naas; Farid El Garch; Gaelle Cuzon; Ariane Deplano; Tugba Delaire; Te-Din Huang; Benedicte Lissoir; Patrice Nordmann; Youri Glupczynski
Journal:  Antimicrob Agents Chemother       Date:  2010-08-30       Impact factor: 5.191

Review 8.  Class A carbapenemases.

Authors:  Jan Walther-Rasmussen; Niels Høiby
Journal:  J Antimicrob Chemother       Date:  2007-06-26       Impact factor: 5.790

9.  Genetic and biochemical characterization of GES-5, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.

Authors:  Il Kwon Bae; You-Nae Lee; Seok Hoon Jeong; Seong Geun Hong; Jung Hun Lee; Sang Hee Lee; Hyoung Jin Kim; Hasik Youn
Journal:  Diagn Microbiol Infect Dis       Date:  2007-04-27       Impact factor: 2.803

10.  Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France.

Authors:  D L Sirot; F W Goldstein; C J Soussy; A L Courtieu; M O Husson; J Lemozy; M Meyran; C Morel; R Perez; C Quentin-Noury
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191
View more
  7 in total

1.  Spread of Klebsiella pneumoniae ST45 Producing GES-5 Carbapenemase or GES-1 Extended-Spectrum β-Lactamase in Newborns and Infants.

Authors:  E Literacka; R Izdebski; P Urbanowicz; D Żabicka; J Klepacka; I Sowa-Sierant; I Żak; A Garus-Jakubowska; W Hryniewicz; M Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

2.  Emergence and Plasmid Analysis of Klebsiella pneumoniae KP01 Carrying blaGES-5 from Guangzhou, China.

Authors:  Ding-Qiang Chen; Ai-Wu Wu; Ling Yang; Dan-Hong Su; Yong-Ping Lin; Yan-Wei Hu; Lei Zheng; Qian Wang
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

3.  Clonal Dissemination of Pseudomonas aeruginosa Sequence Type 235 Isolates Carrying blaIMP-6 and Emergence of blaGES-24 and blaIMP-10 on Novel Genomic Islands PAGI-15 and -16 in South Korea.

Authors:  Jun Sung Hong; Eun-Jeong Yoon; Hyukmin Lee; Seok Hoon Jeong; Kyungwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

4.  Detection of Carbapenemases in Clinical Enterobacteriaceae Isolates Using the VITEK AST-N202 Card.

Authors:  Il Kwon Bae; Hyun-Kyung Kang; In-Ho Jang; Woonhyoung Lee; Keonhan Kim; Jung Ok Kim; Seok Hoon Jeong; Kyungwon Lee
Journal:  Infect Chemother       Date:  2015-09-30

5.  Characterization of Multidrug Resistant Extended-Spectrum Beta-Lactamase-Producing Escherichia coli among Uropathogens of Pediatrics in North of Iran.

Authors:  Mohammad Sadegh Rezai; Ebrahim Salehifar; Alireza Rafiei; Taimour Langaee; Mohammadreza Rafati; Kheironesa Shafahi; Gohar Eslami
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

6.  Complete Nucleotide Sequence of IncP-1β Plasmid pDTC28 Reveals a Non-Functional Variant of the blaGES-Type Gene.

Authors:  Bingjun Dang; Daqing Mao; Yi Luo
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

7.  A report on the presence of GES-5 extended spectrum beta-lactamase producing Pseudomonas aeruginosa associated with urinary tract infection from north-east India.

Authors:  Anand Prakash Maurya; Debarati Choudhury; Anupam Das Talukdar; Anupam Dhar Chanda; Atanu Chakravarty; Amitabha Bhattacharjee
Journal:  Indian J Med Res       Date:  2014-10       Impact factor: 2.375
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.